₨ NPR
MIXTARD-50HM PENFIL (100 IU/ML)
MIXTARD-50HM PENFIL (100 IU/ML) is a pre-mixed insulin formulation used for the management of diabetes mellitus. It contains a precise blend of Human Insulin (soluble, short-acting insulin) and Insulin Isophane (NPH, intermediate-acting insulin) in a 50:50 ratio. This combination is designed to provide comprehensive blood sugar control throughout the day.
-
How it works:
- The short-acting human insulin begins to work relatively quickly (within 30 minutes of injection) to help control the rise in blood sugar levels that occurs after meals (postprandial glucose).
- The intermediate-acting insulin isophane has a slower onset but a prolonged duration of action, providing sustained blood sugar control between meals and overnight.
- Together, these two components work synergistically to facilitate the uptake of glucose from the blood into cells (like muscle and fat cells) for energy, and to suppress the production of glucose by the liver. This helps to maintain stable blood sugar levels and improve overall glycemic control.
-
Formulation and Administration: MIXTARD-50HM PENFIL comes as a suspension for injection in a convenient pre-filled pen device (Penfill). It is administered subcutaneously (under the skin), typically in areas like the abdomen, thigh, or upper arm. Rotating injection sites is crucial to prevent issues like lipodystrophy (changes in fat tissue under the skin). It is generally recommended to inject it 15-30 minutes before a meal.
-
Benefits: By providing both rapid and sustained insulin action, MIXTARD-50HM PENFIL helps to prevent both high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia) when used appropriately and with proper monitoring. Effective blood sugar control is vital in reducing the risk of long-term diabetes complications such as kidney damage (nephropathy), eye damage (retinopathy), nerve damage (neuropathy), and cardiovascular problems.
₨679.00
Ask about productDescription
MIXTARD-50HM PENFIL (100 IU/ML) is a pre-mixed insulin formulation used for the management of diabetes mellitus. It contains a precise blend of Human Insulin (soluble, short-acting insulin) and Insulin Isophane (NPH, intermediate-acting insulin) in a 50:50 ratio. This combination is designed to provide comprehensive blood sugar control throughout the day.
-
How it works:
- The short-acting human insulin begins to work relatively quickly (within 30 minutes of injection) to help control the rise in blood sugar levels that occurs after meals (postprandial glucose).
- The intermediate-acting insulin isophane has a slower onset but a prolonged duration of action, providing sustained blood sugar control between meals and overnight.
- Together, these two components work synergistically to facilitate the uptake of glucose from the blood into cells (like muscle and fat cells) for energy, and to suppress the production of glucose by the liver. This helps to maintain stable blood sugar levels and improve overall glycemic control.
-
Formulation and Administration: MIXTARD-50HM PENFIL comes as a suspension for injection in a convenient pre-filled pen device (Penfill). It is administered subcutaneously (under the skin), typically in areas like the abdomen, thigh, or upper arm. Rotating injection sites is crucial to prevent issues like lipodystrophy (changes in fat tissue under the skin). It is generally recommended to inject it 15-30 minutes before a meal.
-
Benefits: By providing both rapid and sustained insulin action, MIXTARD-50HM PENFIL helps to prevent both high blood sugar (hyperglycemia) and low blood sugar (hypoglycemia) when used appropriately and with proper monitoring. Effective blood sugar control is vital in reducing the risk of long-term diabetes complications such as kidney damage (nephropathy), eye damage (retinopathy), nerve damage (neuropathy), and cardiovascular problems.
Additional information
| form | INSULIN GLULISINE |
|---|
Reviews
There are no reviews yet.